BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24346924)

  • 1. Allogeneic hematopoietic stem cell transplantation in mycosis fungoides.
    Atalla A; Hallack Neto AE; Siqueira DB; Toledo GC
    An Bras Dermatol; 2013; 88(6 Suppl 1):216-9. PubMed ID: 24346924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation.
    Masood N; Russell KJ; Olerud JE; Sabath DE; Sale GE; Doney KC; Flowers ME; Fefer A; Thompson JA
    J Am Acad Dermatol; 2002 Jul; 47(1):140-5. PubMed ID: 12077596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.
    Virmani P; Zain J; Rosen ST; Myskowski PL; Querfeld C
    Dermatol Clin; 2015 Oct; 33(4):807-18. PubMed ID: 26433851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
    J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of mycosis fungoides treated by reduced-intensity cord blood transplantation.
    Tsuji H; Wada T; Murakami M; Kashiwagi T; Ito Y; Ishida-Yamamoto A; Jimbo J; Shindo M; Sato K; Kohgo Y; Iizuka H
    J Dermatol; 2010 Dec; 37(12):1040-5. PubMed ID: 21083707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Domingo-Domenech E; Duarte RF; Boumedil A; Onida F; Gabriel I; Finel H; Arcese W; Browne P; Beelen D; Kobbe G; Veelken H; Arranz R; Greinix H; Lenhoff S; Poiré X; Ribera JM; Thompson J; Zuckerman T; Mufti GJ; Cortelezzi A; Olavarria E; Dreger P; Sureda A; Montoto S
    Bone Marrow Transplant; 2021 Jun; 56(6):1391-1401. PubMed ID: 33420392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.
    Johnson WT; Mukherji R; Kartan S; Nikbakht N; Porcu P; Alpdogan O
    Chin Clin Oncol; 2019 Feb; 8(1):12. PubMed ID: 30525754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
    Duvic M; Donato M; Dabaja B; Richmond H; Singh L; Wei W; Acholonu S; Khouri I; Champlin R; Hosing C
    J Clin Oncol; 2010 May; 28(14):2365-72. PubMed ID: 20351328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).
    Atilla E; Atilla PA; Bozdag SC; Yuksel MK; Toprak SK; Topcuoglu P; Akay BN; Sanli H; Gurman G; Ozcan M
    Int J Hematol; 2017 Sep; 106(3):426-430. PubMed ID: 28466385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
    de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ;
    Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation.
    Frederiks AJ; Creeper KJ; Spagnolo DV; Cannell P; Radeski D
    Australas J Dermatol; 2021 Aug; 62(3):e400-e403. PubMed ID: 34028795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides].
    Hoff NP; Groffik A; Mota R; Pippirs U; Hengge UR; Kobbe G; Homey B; Bruch-Gerharz D
    Hautarzt; 2008 Oct; 59(10):779-82. PubMed ID: 18773178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome.
    Mori T; Shiratori S; Suzumiya J; Kurokawa M; Shindo M; Naoyuki U; Katsuto T; Miyamoto T; Morishige S; Hirokawa M; Fukuda T; Atsuta Y; Suzuki R
    Hematol Oncol; 2020 Aug; 38(3):266-271. PubMed ID: 32011008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is it possible to cure a patient with mycosis fungoides? A case report].
    Guillermo-Villanueva VA; Ruiz-Delgado GJ; del Carmen Tarín-Arzaga L; Gómez-Almaguer D
    Gac Med Mex; 2007; 143(3):249-51. PubMed ID: 17722454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.
    Goyal A; O'Leary D; Foss F
    Bone Marrow Transplant; 2024 Jan; 59(1):41-51. PubMed ID: 37853164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
    Goyal A; Foss F
    Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma.
    Guitart J; Wickless SC; Oyama Y; Kuzel TM; Rosen ST; Traynor A; Burt R
    Arch Dermatol; 2002 Oct; 138(10):1359-65. PubMed ID: 12374543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
    Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
    J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect.
    Burt RK; Guitart J; Traynor A; Link C; Rosen S; Pandolfino T; Kuzel TM
    Bone Marrow Transplant; 2000 Jan; 25(1):111-3. PubMed ID: 10654025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.